Concepedia

The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis

Kevin J. Scully, Peter Marchetti, Gregory S. Sawicki, Ahmet Uluer, Manuela Cernadas, R. Cagnina, John C. Kennedy, Melissa S. Putman

Journal of Cystic Fibrosis · 2021 · 83 citations · 24 references

DOIFull text

Open access

Concepts

References

24

A CFTR Potentiator in Patients with Cystic Fibrosis and the <i>G551D</i> Mutation

Bonnie W. Ramsey, Jane C. Davies, Noel G. McElvaney et al. · New England Journal of Medicine · 2011 · 2.1K citations · Full text

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>

Claire Wainwright, J.S. Elborn, Bonnie W. Ramsey et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials

Roy W. Beck, Richard M. Bergenstal, Tonya D. Riddlesworth et al. · Diabetes Care · 2018 · 742 citations · Full text

Clinical Care Guidelines for Cystic Fibrosis–Related Diabetes

Antoinette Moran, Carol Brunzell, Richard Cohen et al. · Diabetes Care · 2010 · 690 citations · Full text

Ivacaftor in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation

Patrick A. Flume, Theodore G. Liou, Drucy Borowitz et al. · CHEST Journal · 2012 · 327 citations · Full text

, , +9